Cancer Health Treatment Update Oncologists Urge Americans to Get Cancer Screenings Back on Track Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic. Bariatric Surgery Lowers Cancer Risk Weight-loss surgery reduced obesity-related cancers in people with fatty liver disease. FDA Approves Trodelvy for Advanced Bladder Cancer The antibody-drug conjugate shrank tumors in 28% of people with locally advanced or metastatic urothelial cancer. News From the American Association for Cancer Research Annual Meeting See our latest reports on cancer diagnosis, new therapies, disparities in care and more. Advertisement 4 Things to Know About the J&J COVID Vaccine Pause Health officials have paused distribution to investigate a rare blood clotting disorder. More News About COVID-19 For more news about the novel coronavirus and COVID-19, including how it affects people living with cancer, visit our sister site, COVID Health.com. Cancer Health Spring 2021 Check out our latest print edition! Newsfeed ‘She is My Inspiration’: Glioblastoma Patient Watches His Daughter Grow Up American Cancer Society Names Its First Woman CEO In Its 107 Year History Leukemia Survivor Rikako Ikee Qualifies for Summer Olympics Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine Blog: Food and Drug Administration (FDA) FDA Approves New Sarclisa Regimen for Multiple Myeloma FDA Approves Yescarta for Follicular Lymphoma FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer FDA Approves Pepaxto for Heavily Treated Multiple Myeloma Newsfeed ‘She is My Inspiration’: Glioblastoma Patient Watches His Daughter Grow Up American Cancer Society Names Its First Woman CEO In Its 107 Year History Leukemia Survivor Rikako Ikee Qualifies for Summer Olympics Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine Blog: Food and Drug Administration (FDA) FDA Approves New Sarclisa Regimen for Multiple Myeloma FDA Approves Yescarta for Follicular Lymphoma FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer FDA Approves Pepaxto for Heavily Treated Multiple Myeloma

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: